The XOMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XOMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The XOMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View XOMA Detailed Price Forecast - CNN Money||View XOMA Detailed Summary - Google Finance|
|View XOMA Detailed Summary - Yahoo! Finance||View XOMA Stock Research & Analysis - Zacks.com|
|View XOMA Trends & Analysis - Trade-Ideas||View XOMA Major Holders - Barrons|
|View XOMA Call Transcripts - NASDAQ||View XOMA Breaking News & Analysis - Seeking Alpha|
|View XOMA Annual Report - CompanySpotlight.com||View XOMA OTC Short Report - OTCShortReport.com|
|View XOMA Fundamentals - TradeKing||View XOMA SEC Filings - Bar Chart|
|View Historical Prices for XOMA - The WSJ||View Performance/Total Return for XOMA - Morningstar|
|View the Analyst Estimates for XOMA - MarketWatch||View the Earnings History for XOMA - CNBC|
|View the XOMA Earnings - StockMarketWatch||View XOMA Buy or Sell Recommendations - MacroAxis|
|View the XOMA Bullish Patterns - American Bulls||View XOMA Short Pain Metrics - ShortPainBot.com|
|View XOMA Stock Mentions - StockTwits||View XOMA Stock Mentions - PennyStockTweets|
|View XOMA Stock Mentions - Twitter||View XOMA Investment Forum News - Investor Hub|
|View XOMA Stock Mentions - Yahoo! Message Board||View XOMA Stock Mentions - Seeking Alpha|
|View Insider Transactions for XOMA - SECform4.com||View Insider Transactions for XOMA - Insider Cow|
|View XOMA Major Holdings Summary - CNBC||View Insider Disclosure for XOMA - OTC Markets|
|View Insider Transactions for XOMA - Yahoo! Finance||View Institutional Holdings for XOMA - NASDAQ|
|View XOMA Stock Insight & Charts - FinViz.com||View XOMA Investment Charts - StockCharts.com|
|View XOMA Stock Overview & Charts - BarChart||View XOMA User Generated Charts - Trading View|
XOMA Reports Fourth Quarter and Full Year 2018 Financial Results and Operating Highlights
Posted on Thursday March 07, 2019
Added seven new partner-funded programs in 2018 with potential for milestone and royalty paymentsCurrent cash balance sufficient to fund operations for multiple years.
XOMA to Present at the Cowen and Company 39th Annual Health Care Conference
Posted on Tuesday March 05, 2019
XOMA Corporation (XOMA) announced today its Chief Executive Officer, Jim Neal, will present an update about the company’s business at the Cowen and Company 39th Annual Health Care Conference in Boston, Massachusetts. The presentation will take place on Tuesday, March 12, 2019, at 12:00PM ET, and can be accessed via a live webcast on the investor relations page of XOMA’s website at www.xoma.com. An archived version of the webcast will be available for 90 days after the event. XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies. The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas. Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics. The Company’s royalty-aggregator business model includes acquiring additional licenses to partner-funded programs. XOMA’s license portfolio has the potential to generate significant milestone payments and royalty revenue in the future. For more information, visit www.xoma.com.
XOMA Receives $5.5 Million Payment from Rezolute
Posted on Wednesday February 13, 2019
XOMA Corporation (XOMA) announced today it has received a $5.5 million payment from Rezolute, Inc., related to the Companies’ 2017 license agreement, as most recently amended on January 7, 2019. “Our business model is fundamentally designed to generate significant long-term royalty-based revenue as the underlying assets are commercialized. Moreover, many of our license agreements include the potential for XOMA to receive significant milestone payments as the licensed assets progress. The receipt of this milestone payment is a good example of XOMA further strengthening its balance sheet with additional non-dilutive capital. This capital can be deployed to further expand our portfolio of assets from which we have the potential to earn future milestone payments and royalties,” commented Jim Neal, Chief Executive Officer at XOMA.
How Much Are XOMA Corporation (NASDAQ:XOMA) Insiders Spending On Buying Shares?
Posted on Monday February 04, 2019
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! We've lost count of how many times Read More...